title: Is there a standard adjuvant treatment for colon cancer?
authors.affiliation: Department of Medical Oncology, St Bartholomew's Hospital, London, U.K.
authors.forename: M L
authors.initials: ML
authors.lastname: Slevin
authors.forename: D
authors.initials: D
authors.lastname: Papamichael
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
mesh_terms: D000931:Antidotes / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002985:Clinical Protocols; D003110:Colonic Neoplasms / Q000473:pathology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007978:Levamisole / Q000008:administration & dosage; D011379:Prognosis
chemical_list: D000931:Antidotes; D007978:Levamisole; D005472:Fluorouracil